SCHEMBL20122558

SCHEMBL20122558

CC(C)OC(=O)[C@H](CSC(=O)OCOC(=O)c1ccccc1)NC(=O)C(C)(C)SC(=O)OCOC(=O)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 2/20 0.38
▸ ADRB1 P08588 2/20 0.38
▸ ADRB3 P13945 2/20 0.38
▸ HTT P42858 3/20 0.37
▸ PDCD1 Q15116 1/20 0.36
▸ CD274 Q9NZQ7 1/20 0.36
▸ SMN1; SMN2 Q16637 5/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ NPC1 O15118 4/20 0.35
▸ RAB9A P51151 4/20 0.35
▸ LMNA P02545 2/20 0.35
▸ HTR1A P08908 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ SCN1A P35498 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34
▸ SCN5A Q14524 1/20 0.34
▸ SCN2A Q99250 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ SCN3A Q9NY46 1/20 0.34
▸ CTSG P08311 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122516 0.92 ADRB2 (0.41) ADRB2ADRB1ADRB3ALDH1A1LMNA
SCHEMBL20122555 0.91 ADRB2 (0.40) ADRB2ADRB1ADRB3ALDH1A1LMNA
SCHEMBL20122445 0.90 ADRB2 (0.41) ADRB2ADRB1ADRB3ALDH1A1LMNA
SCHEMBL20122365 0.89 ACE (0.40) ADRB2ADRB1ADRB3HTTPDCD1
SCHEMBL20122388 0.89 ADRB2 (0.39) ADRB2ADRB1ADRB3ALDH1A1HTR1A
SCHEMBL20122556 0.89 ADRB2 (0.39) ADRB2ADRB1ADRB3HTTSMN1; SMN2
SCHEMBL20122393 0.88 ADRB2 (0.38) ADRB2ADRB1ADRB3ALDH1A1LMNA
SCHEMBL20122394 0.87 KMT2A (0.42) ADRB2ADRB1ADRB3SMN1; SMN2ALDH1A1
SCHEMBL20122382 0.84 ADRB2 (0.38) ADRB2ADRB1ADRB3ALDH1A1LMNA
SCHEMBL20122500 0.84 ADRB2 (0.40) ADRB2ADRB1ADRB3ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback